cleancap au Search Results


cleancap au  (TriLink)
90
TriLink cleancap au
Cleancap Au, supplied by TriLink, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cleancap au/product/TriLink
Average 90 stars, based on 1 article reviews
cleancap au - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
cleancap® reagent au n-7114-10  (TriLink)
90
TriLink cleancap® reagent au n-7114-10
In vivo expression of LUC after intradermal injection of c-srRNA (A) Schematic diagram of c-srRNA structure. Non-structural proteins (nsP1-nsP4) encode a replica of Venezuelan equine encephalitis virus (VEEV). c-srRNA is produced by in vitro transcription and has a form of mRNA with 5′-Cap and 3′-polyA sequence. No modified nucleosides. (B–D) mRNAs, mRNA-LUC <t>(CleanCap</t> Fluc mRNA [5-methoxyuridine], Tri-Link L-7202) or c-srRNA1-LUC, were prepared as naked RNAs, without LNP or other transfection reagents, in lactated Ringer’s solution. Five microgramsof mRNAs was injected intradermally into a single site on the right hind limb of CD-1 outbred mice (Day 0). Luciferase activity was visualized and quantitated by using a bioluminescent imaging system, AMI HTX (Spectral Instruments Imaging, Tucson, AZ) from Day 1 through Day 26. (B) Representative pictures of mice that received the intradermal injection of mRNA-LUC. (C) Representative pictures of mice that received the intradermal injection of c-srRNA1-LUC. (D) Changes in LUC activities over time for the mice are shown in (B) and (C). Luciferase activity was represented as average radiance.
Cleancap® Reagent Au N 7114 10, supplied by TriLink, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cleancap® reagent au n-7114-10/product/TriLink
Average 90 stars, based on 1 article reviews
cleancap® reagent au n-7114-10 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


In vivo expression of LUC after intradermal injection of c-srRNA (A) Schematic diagram of c-srRNA structure. Non-structural proteins (nsP1-nsP4) encode a replica of Venezuelan equine encephalitis virus (VEEV). c-srRNA is produced by in vitro transcription and has a form of mRNA with 5′-Cap and 3′-polyA sequence. No modified nucleosides. (B–D) mRNAs, mRNA-LUC (CleanCap Fluc mRNA [5-methoxyuridine], Tri-Link L-7202) or c-srRNA1-LUC, were prepared as naked RNAs, without LNP or other transfection reagents, in lactated Ringer’s solution. Five microgramsof mRNAs was injected intradermally into a single site on the right hind limb of CD-1 outbred mice (Day 0). Luciferase activity was visualized and quantitated by using a bioluminescent imaging system, AMI HTX (Spectral Instruments Imaging, Tucson, AZ) from Day 1 through Day 26. (B) Representative pictures of mice that received the intradermal injection of mRNA-LUC. (C) Representative pictures of mice that received the intradermal injection of c-srRNA1-LUC. (D) Changes in LUC activities over time for the mice are shown in (B) and (C). Luciferase activity was represented as average radiance.

Journal: iScience

Article Title: Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity

doi: 10.1016/j.isci.2023.106335

Figure Lengend Snippet: In vivo expression of LUC after intradermal injection of c-srRNA (A) Schematic diagram of c-srRNA structure. Non-structural proteins (nsP1-nsP4) encode a replica of Venezuelan equine encephalitis virus (VEEV). c-srRNA is produced by in vitro transcription and has a form of mRNA with 5′-Cap and 3′-polyA sequence. No modified nucleosides. (B–D) mRNAs, mRNA-LUC (CleanCap Fluc mRNA [5-methoxyuridine], Tri-Link L-7202) or c-srRNA1-LUC, were prepared as naked RNAs, without LNP or other transfection reagents, in lactated Ringer’s solution. Five microgramsof mRNAs was injected intradermally into a single site on the right hind limb of CD-1 outbred mice (Day 0). Luciferase activity was visualized and quantitated by using a bioluminescent imaging system, AMI HTX (Spectral Instruments Imaging, Tucson, AZ) from Day 1 through Day 26. (B) Representative pictures of mice that received the intradermal injection of mRNA-LUC. (C) Representative pictures of mice that received the intradermal injection of c-srRNA1-LUC. (D) Changes in LUC activities over time for the mice are shown in (B) and (C). Luciferase activity was represented as average radiance.

Article Snippet: CleanCap® Reagent AU , TriLink BioTechnologies , N-7114-10.

Techniques: In Vivo, Expressing, Injection, Virus, Produced, In Vitro, Sequencing, Modification, Transfection, Luciferase, Activity Assay, Imaging

Journal: iScience

Article Title: Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity

doi: 10.1016/j.isci.2023.106335

Figure Lengend Snippet:

Article Snippet: CleanCap® Reagent AU , TriLink BioTechnologies , N-7114-10.

Techniques: Virus, Recombinant, Modification, Derivative Assay, Variant Assay, Saline, Plasmid Preparation, Enzyme-linked Immunospot, Double-Color Enzymatic ELISPOT, Enzyme-linked Immunosorbent Assay, Plaque Reduction Neutralization Test, Software, Imaging